Table 2.
Conventional and Speckle tracking echocardiografic mesurements of RV
|
Variable |
Diabetic patients (n=60) |
Controls (n=90) |
p value |
|
EF(%) |
60.2±7.3 |
58.3±4.3 |
NS |
|
TAPSE (cm) |
19±3.2 |
22.2±3.5 |
NS |
|
FAC (%) |
45.3± 6.3 |
46.4±6.4 |
NS |
|
Et (cm/s) |
13.2 ±2.9 |
15.2±3.7 |
<0.05 |
|
At (cm/s) |
13.45± 4.3 |
10.9±3.5 |
<0.05 |
|
Et deceleration time (ms) |
132.6±4.7 |
132.2±4.4 |
NS |
|
Et/At |
0.9 ±1 |
1.3±1.1 |
<0.05 |
|
S’t (cm/s) |
13.2± 2.2 |
13.4±2.5 |
NS |
|
GLS RV global (%) |
-22 4±0.5 |
-22.9±3.3 |
NS |
|
GLS RV FW (%) |
-26.4± 4.3 |
-27.5± 3.9 |
NS |
|
GLS RV bazal (%) |
-25.5 ±4.9 |
-26.5± 5.5 |
NS |
|
GLS RV mid (%) |
-28.7± 4.6 |
-29.4± 4.8 |
NS |
|
GLS RV apex (%) |
-25.3± 6.03 |
-27.2± 5.5 |
NS |